A Japanese case of ovarian mucinous adenocarcinoma with germline double variants of MSH2 and BRCA2.
Rina HaradaHiroyuki MatsubayashiYoshimi KiyozumiHaruki KobayashiKoichi MitsuyaKenichiro ImaiYoichi YamamotoTakuma OishiNobuhiro KadoSeiichiro NishimuraSatomi HigashigawaMasakuni SerizawaPublished in: Journal of human genetics (2023)
Germline double heterozygosity (GDH) is rarely reported in cases of inherited cancer syndromes, and GDH of a mismatch repair gene and BRCA has never been reported in Japan. Nonetheless, the current report demonstrates a case of ovarian mucinous adenocarcinoma with initiated Lynch syndrome (LS)-related surveillance because of a known germline MSH2 variant. Six and a half years after oophorectomy, multiple tumors developed in the patient's lungs, bones, and lymph nodes, and histology results confirmed mucinous adenocarcinoma. Systemic chemotherapy including an anti-PD-L1 antibody was effective for >1 year, but brain metastases developed. Pathology of the brain tumors showed mucinous adenocarcinoma without expression of MSH2 and MSH6, while multi-gene panel testing demonstrated not only high microsatellite instability and a high tumor mutation burden, but also germline BRCA2 variants. Further, germline testing in relatives confirmed both variants were from the paternal line, from which many LS-related cancers develop, but not BRCA-related cancer.
Keyphrases
- copy number
- dna repair
- low grade
- locally advanced
- squamous cell carcinoma
- lymph node
- papillary thyroid
- brain metastases
- breast cancer risk
- small cell lung cancer
- genome wide
- case report
- public health
- squamous cell
- gene expression
- high grade
- rectal cancer
- dna damage
- oxidative stress
- dna methylation
- childhood cancer
- early stage
- long non coding rna
- transcription factor
- young adults
- binding protein
- genetic diversity